Home / Inspections / 1291622

FDA Inspection 1291622 — SPI Pharma, Inc.

SPI Pharma, Inc. — FEI 1833292

The FDA completed an inspection of SPI Pharma, Inc. on September 26, 2025 in Grand Haven, MI. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 26, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Grand Haven, MI (United States)

Facility

Other inspections at this facility

  • 1090151 (NAI Mon Apr 29 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1003696 (NAI Mon Mar 06 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 860789 (VAI Tue Nov 19 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 729481 (NAI Wed May 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 662416 (NAI Wed May 12 2010 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources